2758 Is there a survival benefit for patients who receive post-operative adjuvant chemotherapy following secondary cytoreductive surgery (SCRS) for recurrent epithelial ovarian cancer (EOC)?. (September 2015) - Kolomainen, D.; Butler, J.; Barton, D. P.J.; Taylor, A.; Stanley, K.; Gore, M.; Banerjee, S.